CIGB-300 (P15-Tat)
Cyclic cell-penetrating peptide; CK2 research reagent.
Oncology Research Peptides
iRGD (Certepide / CEND-1) is a synthetic cyclic peptide described in source documentation as a 9-amino-acid structure stabilized by an intramolecular disulfide bridge. It is commonly used in laboratory research involving integrin-binding studies. It is supplied for qualified laboratory research and analytical purposes only.
The source monograph's identifying data (CAS, molecular formula, molecular weight, and full sequence) for this entry duplicated an adjacent Tigapotide monograph in the source document and could not be treated as reliable for this compound. Only the compound identity, class, and research-function description above are drawn from verified text; the CAS number is instead taken from the internal product master list cross-check. Formula, molecular weight, and full sequence are shown as on request pending verified documentation.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Cyclic cell-penetrating peptide; CK2 research reagent.
hTERT-derived 16-mer peptide.
PSP-94-derived 15-mer peptide.